Rigel Pharmaceuticals Inc
RIGL· Nasdaq
RIGLRigel Pharmaceuticals Inc
Released Nov 6, 2012, before the open
10-Q filed Nov 6, 2012, 37 days after period end · 0001104659-12-074445
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q3 2012 | Q3 2011 | Q3 2010 |
|---|---|---|---|
| EPS Diluted | -$0.36 | -$0.25 | $0.96 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Rigel Pharmaceuticals Inc · CIK 1034842 · Engraved from SEC EDGAR
ended Sep 30, 2012 · filed Nov 6, 2012 · 37 d after period end
+1.6% from the close of Nov 5, 2012 to the close of Nov 6, 2012, the first after the release.
